Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sequoia Capital
Biotech
Chai brews up $400M series C to fuel AI used by Lilly and Pfizer
Chai Discovery continued its whirlwind emergence, closing its third financing round in less than a year to bring its total haul above $600 million.
Nick Paul Taylor
Jul 14, 2026 10:03am
Virtue Diagnostics nets $100M for affordable in vitro testing
Jan 6, 2022 10:10am
Metis debuts with $86M to bankroll 2022 trial, gene therapy push
Dec 7, 2021 6:00am
China's Stemirna raises $188M to fund mRNA COVID-19 vaccine
Jun 4, 2021 8:25am
Digital health coach Noom nets $540M to tackle diabetes and more
May 25, 2021 11:25am
Benchling makes the A-team with $200M Series E
Apr 14, 2021 11:36am
